The FDA has only approved Ozempic for those who have diabetes and kidney disease
There are several GLP-1 inhibitors on the market, including Ozempic (semaglutide), Wegovy (semaglutide), and Monjourno (tirzepatide), that are approved for the management of type 2 diabetes
To help ease your concerns, lets examine what to expect from the first month of taking GLP-1 medications, the side effects you may encounter, and what to report back to your physician
Samal S (2021) Utilization of red mud as a source for metal ions-a review
This triggers the effects of the naturally occurring substance (the GLP-1 hormone the body should produce) and tells that cell what to do next (carry out the digestive and metabolic processes the body may struggle to perform on its own)
You can explore related research at PubMed: Pickart, GHK and tissue remodeling (PMID 9763764)